Eckol from Suppresses Immunoglobulin E-mediated Mast Cell Activation and Passive Cutaneous Anaphylaxis in Mice
Overview
Authors
Affiliations
Eckol, a precursor compound belonging to the dibenzo-1,4-dioxin class of phlorotannins, is a phloroglucinol derivative that exerts various activities. In the present study, we investigated the antiallergic effects of eckol isolated from the marine brown algae, using immunoglobulin E (IgE)/bovine serum albumin (BSA)-stimulated mouse bone marrow-derived cultured mast cells (BMCMC) and a mouse model of anaphylaxis. Eckol inhibited IgE/BSA-induced BMCMC degranulation by reducing β-hexosaminidase release. A flow cytometric analysis revealed that eckol decreases FcεRI expression on cell surface and IgE binding to the FcεRI in BMCMC. Moreover, eckol suppressed the production of the cytokines, interleukin (IL)-4, IL-5, IL-6, and IL-13 and the chemokine, thymus activation-regulated chemokine (TARC) by downregulating, IκB-α degradation and NF-κB nuclear translocation. Furthermore, it attenuated the passive cutaneous anaphylactic reaction induced by IgE/BSA-stimulation in the ear of BALB/c mice. These results suggest that eckol is a potential therapeutic candidate for the prevention and treatment of allergic disorders.
Mayer A, Mayer V, Swanson-Mungerson M, Pierce M, Rodriguez A, Nakamura F Mar Drugs. 2024; 22(7).
PMID: 39057418 PMC: 11278370. DOI: 10.3390/md22070309.
Liao M, Wei S, Hu X, Liu J, Wang J Mar Drugs. 2023; 21(7).
PMID: 37504907 PMC: 10381161. DOI: 10.3390/md21070376.
Structures and Anti-Allergic Activities of Natural Products from Marine Organisms.
Chen N, Zhang S, Javeed A, Jian C, Liu Y, Sun J Mar Drugs. 2023; 21(3).
PMID: 36976202 PMC: 10056057. DOI: 10.3390/md21030152.
Wang H, Xiang Q, Lin H, Chen J, Guo W, Guo W Molecules. 2022; 27(5).
PMID: 35268679 PMC: 8912031. DOI: 10.3390/molecules27051577.
Kim E, Han E, Kim J, Fernando I, Oh J, Kim K Mar Drugs. 2022; 20(2).
PMID: 35200662 PMC: 8875385. DOI: 10.3390/md20020133.